Helpdesk

Sales contact

Home > Interoperability

Interoperability

Kayentis and Perceptive eClinical partner to tackle increasing digital system complexity in global clinical trials

Top-tier expertise in electronic Clinical Outcome Assessment (eCOA) and Interactive Response Technology (IRT), combined in seamless integrated solution, will enable sponsors and CROs to streamline clinical trial workflows, reduce digital...

Press Release

Kayentis and Ametris join forces to deliver integrated eCOA solution measuring and improving wearable technology adherence in clinical trials

Interoperability

More than simply unifying wearable and patient-reported data in one app, integrated solution directly tackles major challenge in wearable enabled...

White Paper

Improving the clinical trial journey with technology and system integration

Interoperability

Over the last two decades, the clinical trial landscape has rapidly evolved towards more decentralization and increased use of advanced...

Infographic

How to improve site experience through IRT and eCOA integration?

Interoperability

The Clin’form eCOA solution is ready for integration with any IRT system: benefit from our open eCOA platform to optimize...

Subscribe to our newsletter

Overcoming rare disease trial challenges: the strategic impact of eCOA

Kayentis and Perceptive eClinical partner to tackle increasing digital system...

Raising the bar again: Kayentis achieves 95.9% client Recommendation Rate...

Kayentis and Ametris join forces to deliver integrated eCOA solution...

Breaking barriers in pediatric clinical trials: perspectives from two expert...

Navigating BYOD in Clinical Research: Insights for Clinical Trial Success

About the author

Céline Hollinger

Celine brings almost two decades of communications experience in the life sciences. As a co-founder of a healthcare communication agency for over a decade, she has supported top pharma and innovative healthcare companies. Since April 2019, she has been leading marketing and communication at Kayentis with her innovative strategies.